Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
BeOne Medicines
AstraZeneca
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Seagen Inc.
Seagen Inc.
The Netherlands Cancer Institute
BioNTech SE
M.D. Anderson Cancer Center
Arcus Biosciences, Inc.
M.D. Anderson Cancer Center
Hoffmann-La Roche
M.D. Anderson Cancer Center
AstraZeneca
MedImmune LLC
M.D. Anderson Cancer Center
Akeso
AstraZeneca
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
AstraZeneca
Canadian Cancer Trials Group
Amgen
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
H. Lee Moffitt Cancer Center and Research Institute
EMD Serono
Johannes Gutenberg University Mainz
AstraZeneca
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Daiichi Sankyo
Ohio State University Comprehensive Cancer Center
Replimune Inc.
Canadian Cancer Trials Group
Gilead Sciences
Hoffmann-La Roche
AstraZeneca
Fondazione Ricerca Traslazionale
ETOP IBCSG Partners Foundation
Nuvation Bio Inc.
Fondazione Ricerca Traslazionale
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Fundación GECP
Novartis
Emory University